Related Experiment Video

Updated: Jun 17, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

Valve surgery in congenital heart disease

Giovanni Battista Luciani1

  • 1Division of Cardiac Surgery, University of Verona, Verona, Italy. giovanni.luciani@univr.it

Artificial Organs
|December 22, 2009
PubMed

Insights

Congenital valve disease (CVD) surgery requires tailored approaches for young patients needing multiple interventions. This study reviews surgical outcomes to improve long-term survival and quality of life for individuals with CVD.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Defects

Background:

  • Congenital valve disease (CVD) presents unique challenges including early onset, associated pathologies, and critical presentations.
  • CVD often necessitates multiple surgical interventions, underscoring its palliative nature.
  • Balancing long-term survival with quality of life is crucial for young, active patients with CVD.

Purpose of the Study:

  • To analyze the specific surgical considerations for congenital valve disease.
  • To evaluate treatment options and outcomes in a large cohort of CVD patients.
  • To discuss future directions in managing congenital valve disease.

Main Methods:

  • Retrospective review of clinical experience.
  • Analysis of 565 consecutive patients undergoing surgery for CVD over a 7-year period.
  • Assessment of treatment strategies and patient outcomes.

Main Results:

  • Surgical interventions for CVD were evaluated based on patient-specific demands.
  • Outcomes were analyzed in the context of long-term survival and quality of life.
  • The palliative nature of CVD surgery and its implications were highlighted.

Conclusions:

  • Surgical management of congenital valve disease must address the distinct epidemiological and clinical features of affected patients.
  • Optimizing surgical strategies is essential to meet the long-term survival and quality of life expectations of young patients.
  • Further advancements are needed to enhance the comprehensive management of congenital valve disease.

More Related Videos

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.